- Home
- APYX vs ESLA Comparison
APYX vs ESLA Comparison
Compare APYX & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APYX
- ESLA
- Stock Information
- Founded
- APYX 1982
- ESLA 2021
- Country
- APYX United States
- ESLA United States
- Employees
- APYX N/A
- ESLA N/A
- Industry
- APYX Medical/Dental Instruments
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- APYX Health Care
- ESLA Health Care
- Exchange
- APYX Nasdaq
- ESLA Nasdaq
- Market Cap
- APYX 36.8M
- ESLA 35.5M
- IPO Year
- APYX 1987
- ESLA N/A
- Fundamental
- Price
- APYX $1.60
- ESLA $1.01
- Analyst Decision
- APYX Hold
- ESLA Strong Buy
- Analyst Count
- APYX 2
- ESLA 1
- Target Price
- APYX N/A
- ESLA $16.00
- AVG Volume (30 Days)
- APYX 459.5K
- ESLA 23.1K
- Earning Date
- APYX 05-08-2025
- ESLA 05-14-2025
- Dividend Yield
- APYX N/A
- ESLA N/A
- EPS Growth
- APYX N/A
- ESLA N/A
- EPS
- APYX N/A
- ESLA N/A
- Revenue
- APYX $47,288,000.00
- ESLA N/A
- Revenue This Year
- APYX $2.25
- ESLA $101.09
- Revenue Next Year
- APYX $6.76
- ESLA N/A
- P/E Ratio
- APYX N/A
- ESLA N/A
- Revenue Growth
- APYX N/A
- ESLA N/A
- 52 Week Low
- APYX $0.76
- ESLA $0.63
- 52 Week High
- APYX $1.95
- ESLA $3.23
- Technical
- Relative Strength Index (RSI)
- APYX 58.36
- ESLA 50.50
- Support Level
- APYX $1.52
- ESLA $0.97
- Resistance Level
- APYX $1.72
- ESLA $1.04
- Average True Range (ATR)
- APYX 0.21
- ESLA 0.06
- MACD
- APYX 0.01
- ESLA -0.00
- Stochastic Oscillator
- APYX 71.43
- ESLA 63.27
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.